Sumitoma Pharma US
Pegah Rabby is an accomplished finance executive currently serving as the Vice President of Financial Planning Analysis at Sumitomo Pharma America, Inc. since July 2023. Previously, Rabby held the role of VP of Finance, overseeing FP&A, interim investor relations, and treasury at Myovant Sciences from December 2021 to July 2023. Rabby has extensive experience at Amgen, which includes serving as Head of Finance for the U.S. Neuroscience Business Unit and leading finance integration for the Five Prime Therapeutics acquisition. Rabby has managed significant financial operations, including a $16B P&L and oversight of investment portfolios totaling over $22B. Education credentials include an MBA from UCLA Anderson School of Management and a B.S. in Economics from UC San Diego.
This person is not in any teams
This person is not in any offices
Sumitoma Pharma US
2 followers
Sumitomo Pharma America (SMPA) is a science-based, technology-driven biopharmaceutical company focused on delivering therapeutic and scientific breakthroughs in areas of critical patient need in oncology, urology, women’s health, rare disease, cell and gene therapies and psychiatry and neurology.